Odio-BERT: Evaluating domain task impact in hate speech detection
Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology · 2026-02 · 50 (2) · 336-347
DOI: 10.3233/jifs-219349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology, online erschienen am 29.03.2024. Verfasst von Mesay Gemeda Yigezu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
The rise of social media and micro-blogging platforms has led to concerns about hate speech, its potential to incite violence, psychological trauma, extremist beliefs, and self-harm. We have proposed a novel model, Odio-BERT for detecting hate speech using a pretrained BERT language model. This specialized model is specifically designed for detecting hate speech in the Spanish language, and when compared to existing models, it consistently outperforms them. The study provides valuable insights into addressing hate speech in the Spanish language and explores the impact of domain tasks.
Zitieren
APA
Yigezu, M. G., Kolesnikova, O., Gelbukh, A., & Sidorov, G. (2026). Odio-BERT: Evaluating domain task impact in hate speech detection. Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology, 50(2), 336-347. https://doi.org/10.3233/jifs-219349
Vancouver
Yigezu MG, Kolesnikova O, Gelbukh A, Sidorov G. Odio-BERT: Evaluating domain task impact in hate speech detection. Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology. 2026;50(2):336-347. doi:10.3233/jifs-219349
BibTeX
@article{Yigezu2026,
author = {Yigezu, Mesay Gemeda and Kolesnikova, Olga and Gelbukh, Alexander and Sidorov, Grigori},
title = {Odio-BERT: Evaluating domain task impact in hate speech detection},
journal = {Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology},
year = {2026},
volume = {50},
number = {2},
pages = {336--347},
doi = {10.3233/jifs-219349}
}
EUVIMED